Maximizing TLR9 Activation in Cancer Immunotherapy with Dual-Adjuvanted Spherical Nucleic Acids.
Nano Lett
; 22(10): 4058-4066, 2022 05 25.
Article
in En
| MEDLINE
| ID: mdl-35522597
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Nucleic Acids
/
Cancer Vaccines
/
Toll-Like Receptor 9
/
Immunotherapy
/
Neoplasms
Limits:
Animals
Language:
En
Journal:
Nano Lett
Year:
2022
Type:
Article
Affiliation country:
United States